First look: UAE-made Covid vaccine production begins as Hayat-Vax is rolled out

Hayat — meaning ‘life’ in Arabic — is the first indigenous Covid-19 vaccine in the region to be manufactured by a newly created joint venture between Abu Dhabi’s G42 and Sinopharm. Hayat-Vax is the same Sinopharm vaccine that was registered by the UAE Ministry of Health and Prevention in December last year. In a statement, G42 revealed that the joint venture is already producing Hayat-Vax with its partner — Ras Al Khaimah-based pharma firm Julphar — with an initial capacity of 2 million doses per month.

The UAE has started producing its Covid-19 vaccine called Hayat-Vax and, initially, as many as two million doses can be manufactured in a month, a local entity involved in the process said. https://t.co/qC5pGnoNUo pic.twitter.com/kIy34NaX9U

— Khaleej Times (@khaleejtimes) March 30, 2021